GHRP-6 is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) and one of the earliest characterized members of the growth hormone secretagogue family. In research settings, it is examined for its ability to interact with ghrelin receptors, influence somatostatin activity, and promote pulsatile growth hormone (GH) release. Studies often explore its synergy with GHRH analogues such as Sermorelin and CJC-1295.

Each vial contains 5000 mcg (5 mg) of lyophilized GHRP-6 peptide. Laboratory reference preparations typically use 2 mL of bacteriostatic water to achieve a known concentration for calibration or assay development.

Research Highlights

• Investigated for its role in growth hormone release modulation through somatostatin suppression.
• Commonly referenced in models involving metabolic balance, tissue repair, and recovery kinetics.
• Explored in combination with GHRH analogues for synergistic GH-axis signaling studies.
• Non-toxic peptide structure suitable for cell-based or biochemical assay environments.

Product Specifications

• Compound: Growth Hormone Releasing Peptide-6 (GHRP-6)
• Form: Lyophilized powder (research-grade peptide)
• Content: 5000 mcg (5 mg) per vial

Laboratory Reconstitution Reference

When preparing reference solutions for research, reconstitute under sterile conditions. The following concentration ratios are commonly used for experimental calibration:

• Introduce bacteriostatic water slowly down the vial wall to minimize foaming.
• Swirl gently until fully dissolved—avoid vigorous shaking.
• Label with date of preparation and final concentration.

Research Context

• Focus: Endocrine signaling, peptide-hormone dynamics, and GH-axis modulation models.
• Study Design: Typically used in vitro or in animal models examining peptide-receptor interaction.
• Synergy: Often paired with CJC-1295 or GHRH analogues to evaluate pulsatile effects.

Storage & Stability

• Lyophilized (dry): Store in a light-protected environment.
• Reconstituted solution: Refrigerate at 2–8 °C and use within 30 days.

Package Contents

• 1 × GHRP-6 5000 mcg (5 mg) lyophilized peptide vial
• 1 × 2 mL sterile bacteriostatic-water vial

Quality Assurance — EU Pharmaceuticals

EU Pharmaceuticals peptides are produced in controlled facilities with rigorous identity verification, mass-spectrometry confirmation, and purity validation. Each vial includes batch coding for traceability and consistency across research applications.

For laboratory, educational, and research use only. Not intended for human or veterinary administration, ingestion, or therapeutic use. No medical or performance claims are made or implied. The purchaser is responsible for lawful handling and compliance with all applicable regulations.